These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 2388690)
1. Fast track for AIDS and cancer drugs. Gershon D Nature; 1990 Aug; 346(6286):685. PubMed ID: 2388690 [No Abstract] [Full Text] [Related]
2. The fast track toward new AIDS drugs. Long K; Long R Nurse Pract Forum; 1991 Jun; 2(2):80-1. PubMed ID: 1840952 [No Abstract] [Full Text] [Related]
3. Panel recommends changes to expedite approval of cancer, AIDS drugs. Am J Hosp Pharm; 1990 Nov; 47(11):2410, 2413. PubMed ID: 2278248 [No Abstract] [Full Text] [Related]
4. The fast track: federal agencies and the political demand for AIDS drugs. Foreman CH Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828 [No Abstract] [Full Text] [Related]
5. FDA launches "new use initiative". Nat Biotechnol; 1997 May; 15(5):399. PubMed ID: 9131604 [No Abstract] [Full Text] [Related]
6. FDA expands testing of anti-AIDS drugs. N Y State J Med; 1989 Sep; 89(9):548. PubMed ID: 2552360 [No Abstract] [Full Text] [Related]
7. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS. Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034 [No Abstract] [Full Text] [Related]
8. Experimental AIDS drug d4T, now available to patients in critical need. Ann Allergy; 1993 Sep; 71(3):A24. PubMed ID: 8396862 [No Abstract] [Full Text] [Related]
9. [AIDS, intervention studies and pressure from patients]. Danner SA Ned Tijdschr Geneeskd; 1990 Sep; 134(38):1835-6. PubMed ID: 2215754 [No Abstract] [Full Text] [Related]
10. A faster track for AIDS drugs? Kosterlitz J Natl J (Wash); 1989 Jul; 21(30):1931. PubMed ID: 10293944 [No Abstract] [Full Text] [Related]
11. Cancer and AIDS groups push for changes in drug approval process. Anderson LF J Natl Cancer Inst; 1989 Jun; 81(11):829-31. PubMed ID: 2724348 [No Abstract] [Full Text] [Related]
12. Zidovudine approved by FDA for treatment of AIDS. Clin Pharm; 1987 Jun; 6(6):431,435. PubMed ID: 3319360 [No Abstract] [Full Text] [Related]
13. Stavudine made available under parallel track policy. Clin Pharm; 1993 Jan; 12(1):7. PubMed ID: 8381342 [No Abstract] [Full Text] [Related]
14. New AIDS drug poised to move into development. Science; 1991 Dec; 254(5039):1715. PubMed ID: 1763318 [No Abstract] [Full Text] [Related]
15. Editorial: time to end the death trials. James JS AIDS Treat News; 1996 Aug; (no 252):1-4. PubMed ID: 11363751 [TBL] [Abstract][Full Text] [Related]
16. AIDS drugs in research. Hosp Pharm; 1990 Jun; 25(6):572-3, 576. PubMed ID: 10104831 [No Abstract] [Full Text] [Related]
17. AIDS fraud, finances, and fringes. Sampson WI N Y State J Med; 1993 Feb; 93(2):92-6. PubMed ID: 8455840 [No Abstract] [Full Text] [Related]
18. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration. AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038 [TBL] [Abstract][Full Text] [Related]
19. The development of new cancer drugs: a joint venture in public policy by the National Cancer Institute and Food and Drug Administration. Crout JR Cancer Treat Rep; 1982 Sep; 66(9):1705-7. PubMed ID: 6811133 [No Abstract] [Full Text] [Related]
20. [Treatment of neutropenia in HIV infection with hematopoietic growth factors]. Moreno García M; Fernández González F Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065 [No Abstract] [Full Text] [Related] [Next] [New Search]